RVV Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): C$14,370.00
Insider Selling (Last 12 Months): C$0.00

Revive Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Revive Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Revive Therapeutics Share Price & Price History

Current Price: C$0.08
Price Change: Price Increase of +0.01 (14.29%)
As of 07/22/2019 09:54 PM ET

This chart shows the closing price history over time for RVV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Revive Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/18/2024Michael FrankDirectorBuy150,000C$0.04C$5,250.00
3/15/2024Michael FrankDirectorBuy304,000C$0.03C$9,120.00
7/30/2021Derrick Alexander WelshDirectorBuy45,000C$0.51C$22,896.002,045,000
See Full Table

SEC Filings (Institutional Ownership Changes) for Revive Therapeutics (CVE:RVV)

Revive Therapeutics logo
Revive Therapeutics Ltd. develops and commercializes cannabinoid-based products in Canada. The company develops REV-002, a bucillamine that has completed Phase II-A clinical studies for the treatment of acute gout flares. Its product pipeline also includes REV-004, a bucillamine for the treatment of cystinurial. The company has a research and development supply and collaboration agreement with WeedMD Inc. Revive Therapeutics Ltd. was incorporated in 2012 and is headquartered in Vaughan, Canada.
Read More on Revive Therapeutics

Today's Range

Now: C$0.08
Low: C$0.08
High: C$0.09

50 Day Range

MA: C$0.08
Low: C$0.08
High: C$0.08

52 Week Range

Now: C$0.08
Low: C$0.07
High: C$0.25


212,852 shs

Average Volume

93,085 shs

Market Capitalization

C$5.79 million

P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Revive Therapeutics?

Revive Therapeutics' top insider shareholders include:
  1. Michael Frank (Director)
Learn More about top insider investors at Revive Therapeutics.